BFKW: Funding, Investors & Team (Oct 2026)
BFKW has developed the Full Sense™ Device – a temporary device that is implanted and extracted via endoscopy and induces long lasting satiety leading to significant weight loss. This device, once introduced may radically change the current treatment for obesity by eliminating the need for gastric banding, gastric bypass and intragastric balloon surgeries. The Company has strong patent protection with patents issued or in final review (pending) in all of our target markets of the United States (US), European Union (EU), Australia, China and Russia and numerous other jurisdictions. The Full Sense™ Bariatric Device has undergone successful preclinical evaluations, has been implanted in over 50 patients with zero non-responders with excess body weight loss exceeding results seen with gastric bypass and gastric banding.
BFKW has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Nov 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BFKW Company Profile and Key Stats
Latest funding round on record: Nov 2024.
BFKW Funding Rounds
BFKW Founders and Leadership Team
No contact details are on record for this team yet.
BFKW Funding Compared to Other Biotechnology Startups
BFKW's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BFKW in Biotechnology and Grand Rapids
Companies Similar to BFKW
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BFKW Funding FAQs
What does BFKW do?
BFKW has developed the Full Sense™ Device – a temporary device that is implanted and extracted via endoscopy and induces long lasting satiety leading to significant weight loss. This device, once introduced may radically change the current treatment for obesity by eliminating the need for gastric banding, gastric bypass and intragastric balloon surgeries. The Company has strong patent protection with patents issued or in final review (pending) in all of our target markets of the United States (US), European Union (EU), Australia, China and Russia and numerous other jurisdictions. The Full Sense™ Bariatric Device has undergone successful preclinical evaluations, has been implanted in over 50 patients with zero non-responders with excess body weight loss exceeding results seen with gastric bypass and gastric banding.
How much funding has BFKW raised?
BFKW has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Nov 2024.
When did BFKW last raise funding?
BFKW's most recent funding round on record is an undisclosed round of $500k, announced in Nov 2024.
Who founded BFKW?
FundedIQ lists Randal Baker (Founder) at BFKW.
Where is BFKW headquartered?
BFKW is based in Grand Rapids, Michigan, United States.
How many employees does BFKW have?
BFKW is in the 1-10 employee band.
How does BFKW's funding compare to other Biotechnology startups?
BFKW's latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BFKW Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BFKW is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.